Karel Kostev։ When First Anticoagulant Prescriptions Are Not Dispensed
Karel Kostev, Senior Scientific Principal at IQVIA, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Cardiovascular Development and Disease, adding:
”New publication in the Journal of Cardiovascular Development and Disease.
How often is a first oral anticoagulant prescription for atrial fibrillation (AF) never dispensed?
We analysed 57,290 first prescriptions in 53,815 AF patients in Germany (2016–2025), using the IQVIA Disease Analyzer and LRx databases.
Key findings:
- Primary non-adherence (PNA), i.e. no dispensing within 30 days, occurred in 10.6 percent of prescriptions
- PNA was highest for vitamin K antagonists (14.4 percent) and lowest for apixaban and edoxaban (9.6 percent each)
- Direct factor Xa inhibitors were associated with 33 percent lower odds of PNA than vitamin K antagonists
- Prior myocardial infarction and dementia were associated with lower PNA; ischemic heart disease and hypertension with higher PNA
- Almost half of non-dispensed prescriptions were dispensed later
- Non-dispensing of the first prescription was strongly associated with later non-dispensing
General practitioners and pharmacists can use these findings to confirm early whether anticoagulation has actually started, especially for vitamin K antagonists.”
Title: Primary Non-Adherence and Associated Factors in Patients with Atrial Fibrillation in Germany: A Retrospective Cohort Study
Authors: Karel Kostev, Beate Leppert, Maximilian Peters, Henning Sievert, Marcel Konrad, Mark Luedde

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC